Citation tools
"Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group." European Respiratory Journal
10.10
(1997):
2260-2263.
Web. 09 Dec. 2024.